Fundz

AbCellera Biologics Inc. Appoints Victor Sandor as Director

PUBLIC · ABCLJun 05, 2026

Position

Director

Company

AbCellera

Victor Sandor
BiotechnologyHealth CarePharmaceutical

Description

On June 1, 2026, AbCellera Biologics Inc. appointed Victor Sandor as a new director. He will serve until the Company’s next annual meeting of shareholders or until his earlier resignation or removal

Quick answer

AbCellera Biologics Inc. Appoints Victor Sandor as Director (June 5, 2026).

Who is the new Director at AbCellera?
AbCellera named Victor Sandor Director, announced June 5, 2026.
What did AbCellera announce on June 5, 2026?
On June 1, 2026, AbCellera Biologics Inc. appointed Victor Sandor as a new director.
What does AbCellera do?
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology.
Which similar companies made leadership changes around the same time?
Revium Rx (June 1, 2026), Poxel (June 10, 2026), Retension Pharmaceuticals (May 27, 2026) and Cencora (May 27, 2026) also announced leadership changes within 45 days of AbCellera.

Source: Fundz verified event record.

Other recent leadership changes in Pharmaceutical and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at AbCellera, and when

A new leader at AbCellera brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day AbCellera raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AbCellera, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AbCellera. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AbCellera

About

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AbCellera changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Carl
Likely contact at this company
••••••••@••••••••

See Carl's verified email →

Simita
Likely contact at this company
••••••••@••••••••

See Simita's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for AbCellera's next move

Learn about Strategic plan

AbCellera changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.